hn2301
Nucleic acidexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Mar 16, 2025 (NCT06801119)
Timeline
No events for the selected filters.
Mechanism of action
- Isocitrate dehydrogenase [NADP] cytoplasmicANTISENSE INHIBITOR
IDH1 antisense inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06965309 | N/A | Jun 30, 2025 | Government of China |
| NCT06801119 | N/A | Mar 16, 2025 | Government of China, University of Science and Technology of China |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Government of China | Government | 2 | 2 | 1 | 2025 |
| University of Science and Technology of China | Academic/Hospital | 1 | 0 | 1 | 2025 |
2 organizations
Page 1 / 1